Screener Summaries Updates Institutions Sign In More Updates › Other Events › VANI Other Events · Jul 16, 2026
Vivani Medical, Inc. presented at the Emerging Growth Conference in New York on July 15, 2026 VANI Vivani Medical, Inc.
Vivani Medical, Inc. presented at the Emerging Growth Conference in New York on July 15, 2026. During the presentation, CEO Dr. Adam Mendelsohn provided an update stating that the first dosing of the company's SLIM-1 is expected to occur in August 2026. Vivani Medical, Inc. is a biotechnology company focused on developing medical treatments.
More from Vivani Medical, Inc. Vivani Medical says merger with ClearOne pending final regulatory approval Oct 30, 2026 Vivani Medical expects to price and close merger with ClearOne via subsidiary Cortigent in October 2026 Sep 16, 2026 Vivani Medical announced the successful dosing of all participants in its SLIM-1 Phase 1 clinical trial for NPM-139, a… Aug 6, 2026 Vivani Medical, Inc. entered into a definitive merger agreement on July 1, 2026, where its subsidiary Cortigent, Inc.… Jul 7, 2026 Vivani Medical, Inc. stockholders' 2thought: 2026 Annual Meeting results show the approval of the 2022 Amended Plan… Jun 30, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
